{"ticker": {"uuid": "f8af74e2-0372-465c-b306-2b47187ca083", "symbol": "NOVOBN", "name": "Novo Nordisk A/S", "exchange": "MEX", "country": "MX", "sector": "Healthcare", "industry": "Drug Manufacturers - General"}, "articles": [{"title": "Novo Nordisk: A Fallen Leader Trading At Fair Value, Not A Bargain (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQeGJOZDdTMGFXYUVxblRqZkF1VXRjcnFQSTVlRG5oX2NabHdBOUVoVm1fNnZsRjQwdFQyblpxcTdoYmFjaU9FdVBOMHdsRm9sUGhDdmFBWVhFelJnc0prQkpGaHZTY2tLQ21kT0lHaEMyTVpadHREbm5lN1ZKSi0yQ2VzRzdGajF3RmFEWDVyMzZnYXVBS1JQbF8tTjNYUUlFNnRVaHZ1MFE?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-17T07:39:58+00:00", "published_display": "17 Jun 2026 07:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk lifts 2026 outlook as Wegovy drives growth; shares jump", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOUHFDeGlNX05nd2l6OE5qYnEwRDhLdkl4bWlnanBvaXQwQUEtLW13bTNURVdBOXlSenJoU1R5YXp4MFBIVkktR0JaWWR3UUlhSFV1TUJCLUN4QnM5OFo4XzNwdHZiMm9CRzlsZDZ3ZU9TNzF5emZRSGhtVGhDMElyZHBTb2hxZGNSRWZfMThSUnpvcFdBdndUQmhLbnZjNDVWM2E2SGJB?oc=5", "source_name": "Investing.com", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk's Weight Loss Doesn't Mean To Load Up (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQQS1MWUpaY19uYWFNZGhHdlZ0VzU1WFowb1BJYXp0VWt3Z19kUzlmQ1k5cnJYTVVYX3otczFHdzdBMWd1NXl4S21YSTJIR1JLcGQ2RWh0V00tOVA2WW5zV2Eza1BQb3NQRnJEMXJOa3g3V0c1Sm10VFhSNEMxVXlkQ3lkczcwNVVtUnZfWE80X2owZmc?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk Just Announced Wegovy Subscriptions. Does That Make NVO Stock a Buy?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNeUFjeXNmZHFzWlZ0dC1jdVlpaDZYYVBVT1YxdGlTMXBibUVGbm9iejdDYW5ZSktsM3ZzREw3YXJLSVlscGNBZFJobnFSem5JaHNDQkZGZTMtTGtta2lfMG1GR3U0eWpMYzNSQmFIa1JwV0pkS3VzemJ0ZlJrLWdaTFRadHNmSUtSQ0dZcWhoMEJwSTlYV09ZcUYzS1lUYWNEWEZyTFBfMDN0aXRiLVNJVWpzYjNzT3l3ZDJfU3Y3eFE?oc=5", "source_name": "Barchart.com", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk stock falls after FDA warning letter", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxNUjZ5WjRrMXp1eXZKemhHWTRYSGlrRk0xRE56blhjREdKNzAtNG1nVkxWOTJIblZhZVhCX3RKM011OHpMZDdUQnJZVWMyNE1tRTFvWmswTldiT3Q3UWdLVGtDdVB5WUFLQ01oWnM3cTlJUUt4WFE5RDJqWnVCV0xWd2JnNlJCZzNuSTNUS1JqUk41eG9iQjRScFZOdHhWa0hfSDBoOVVENmdzeWxIMnhvVg?oc=5", "source_name": "Investing.com", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 6, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here Are Monday\u2019s Top Wall Street Analyst Research Calls: AppLovin, Blue Owl Capital, CrowdStrike, Dutch Bros., Jet Blue, Novo Nordisk, PayPal, Twilio, and More", "summary": "", "url": "https://news.google.com/rss/articles/CBMingJBVV95cUxNaUtPUHB2NkdObG5LcDN6V2ctZEJMbEYzYktVNnhOMkdIekxkVEwwc3dxLV9KU0VnVjhWUFNlbXRrb09GMGk2eklxaWI5TmRWbmVuT0V6dHo5VzJwU2NwSDVZRHAwTDgzaTFTNW5CanJOOHJxU0JaMWw0UEJoX01FU0g4UXV6U1dhODlhU1BodFhBYWJPTUFqVFcxeWFWOW04NEVJNG9qTUgtdjNhUXZsUTEzcHh6b3lxcUJ2UFV0QWRORFRzS1NKRFFLU3RaLTV3RVQ3dmRmaF92bGk0XzNTYVktSUtBRjFUNll0UXlGRnd1clg2V0pwTjZuUW4zUTF1YnZtM2JTbjhVSXpSY3EzSUQwMGVmUDVURXZ6UGNB?oc=5", "source_name": "24/7 Wall St.", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk's $475-billion rise and fall as Wegovy-era gains wiped out", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxPaTdmamc4QU9IekYyT2hOdlVOdlowVjFnZE84b29mN3RuNXFUMURRaUEwTUkzMEwxVllJT3NzdHo3ZjNoYmJmZk41QUpkSTRacmdCd2ZpSVkxdE1icFVXUVVOVUExblRobUpuT2FUSV8td3dCUS00dm5NYU5LYmFTTEdLT0lhQm9naEczT2lySU9GSS1ZUFpEZnNCemFVUk9lejMxR2RBVFNScFBRamlpbEpjQU1iX0RmVjlJVXZJR0k2T2dGZkJWVWItaDY4czE3YkdTT1Fab05tUQ?oc=5", "source_name": "Reuters", "published_at": "2026-02-23T08:00:00+00:00", "published_display": "23 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk Files Patent Lawsuit Against Hims & Hers Over Compounded Semaglutide Products", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxOcUtRUG1LbTVybjF5NTliRXRIeGV3TWVGTGxxT1psSWU5VXQzb0RPQ0RSQWJWWVVQRHVQY0VfOXRJTTdubnVvQWpzWHh4XzRScGFCbEhDODFndUZuVlJ6c25nSnk0VHhkdk1Xd3g5UDdLWmhVb2JLWER4M1l3bjBLUW5NV1hFZFktbWNCTGpzQnU1SUFXV0oyY1dzaVpzdm9jSzc2NnhRbDRrU1ZQRnlqclpLRlUzOTB4b2ZUWVdHOHhJTk9KSVE?oc=5", "source_name": "Law Commentary", "published_at": "2026-02-10T08:00:00+00:00", "published_display": "10 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk shares fall 18% amid lower 2026 sales outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxOQTNhNGZrQ0VEYUxXdllVYzFTRFJRd0VNVlBmS190dE9aRnoyaEtTbnFQTFcyQkVBN1YxYi1sZ0xrZVVWWmg1WW9wTTQzNzdxMFQyVkt4MFZPeEwwbFdnUmF1eGZsZFBleGVtVnVveGZhOFlqUHlOVlZqc0xFQWdBYUVMMS1tNGlPYmRjbU9Iak5KQVh2dW95M0pxM3lQRzFPVWJnRHpzUE9wVUVNNl82eWVPZw?oc=5", "source_name": "Investing.com", "published_at": "2026-02-03T08:00:00+00:00", "published_display": "03 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 6, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk stock soars after FDA approves first oral GLP-1 for weight loss", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxQbkVMUHNPalZHMWRMdUhhT0RSTTBhcDhiel9IcnBmcWNJaWdpclpPMGJjS09yN1VCR1UwVU1IVTlHaEsyQUtxVGFDMXA1ODdUVTFDTmlPWDNjWnQybFB2LU44VXN5aXlpSUxiNGxkNG1IeUE4cVZUOGJMcTRrcTAtcTNXLTJQWWhXaXA5OVUwdlB4RVJwTnk4RG5mN0RINFlSVjVoNXlEdXNlWDZsZkVLVC1nTGVsclJKVEF1MmtMaTZSX0NKNmNtcDJlRFA?oc=5", "source_name": "Investing.com", "published_at": "2025-12-22T08:00:00+00:00", "published_display": "22 Dec 2025 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk's weight-loss challenge in five charts", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxOU1lnS1hva0V3RVpkMl9ZODdJTl9IeVF2UmtQSEVLRFc0VFVCMHpvVDlJZmdrb25BZUlJWlhXUm1Gc212eDk3N1VnQzRta2xSbk9rRFl2TW5vS01nRjFSSThmTE1Idk5qTXc5S2h5RlBzSk1KMWtKMGlTSEhoQ0tsNkItWVNvak5zd1BudzczWlNqWVF0ckIwdkRqTU9JNnE2ZGFqMnNYLTdndVJ2Uy1hU3BtSDc0OVNEclJz?oc=5", "source_name": "Reuters", "published_at": "2025-11-05T08:00:00+00:00", "published_display": "05 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk shares fall as top investor drives board overhaul", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPY2I5NWtFb1VfSDVmdVRyNDhzUUFrcGpOTW56RUE1SWlOaG5nRHRTLU1kMmFxbXdIckNYaU9POXlMLUVzYXB3TjZOcTY3RU1oU3VxemMydXNDLWJvS1BHS2wtMmlpQWlFaHdWckpMOUd3cmFkWkJ1ZnprRXA4ejhObjRWd000RjBiUVRxWHZWeWFUYkpBM3RxcXJNYzlPejctcGVsdGJNWQ?oc=5", "source_name": "Reuters", "published_at": "2025-10-22T07:00:00+00:00", "published_display": "22 Oct 2025 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shares in Novo Nordisk rise after Wegovy gets US nod for liver disease treatment", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxPRUwxUEJDOWFiRUpWQTlOell4VDlsR0hlbDdZR2dfN2FMMVZLRkctNmhORjU4UnVxOUZ1NTU0RXpPTmxwR1lxd0JCcjd3VS1zbHd2RUFBYXh1Z0t5SGs1QnRIM3RNXy1KUDRQWHRCNDI4bk9pb0ZoYml6ZTNndDI4b0NBVzVtX1M0T01rd0xER0lSaHNlQkdKT0MyODZ6WWJBQUh5MUN2dTZXMGJnZXgyMzRSMV92VERiRkZyYWYyMUpNeGI1bEwtUU93R0F2TVZRRVdlak9RVEVGdnlKYUE?oc=5", "source_name": "Reuters", "published_at": "2025-08-18T07:00:00+00:00", "published_display": "18 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk shares fall as obesity pipeline faces investor scrutiny", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxPRURhLU1RbmZtejlyY2lXU2pxeGlXQjlCcHpsOW9uWXNGUTVqMEtCb2VtNDY5cU1yNFliblFXQkZiLWdVbTYxOVVEZkROMGk1UkpTOUJ5Q1pURjRza0t2QjJmcHIwY2Vuc2hIdko1YlB5VjYyTU56d055SFhxdWtLbkFydU9JUFVlTFdzU0g0bEUtRU9hZ1ZZcm9SWC12cU85bFA2LWFndk5WLXVKeU5EclJTSXdTMEM5d19xVkxLRVVERUJSN0hMTnZxV2Rqc2VVcXNz?oc=5", "source_name": "Reuters", "published_at": "2025-06-23T07:00:00+00:00", "published_display": "23 Jun 2025 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Novo Nordisk: A Fallen Leader Trading At Fair Value, Not A Bargain (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQeGJOZDdTMGFXYUVxblRqZkF1VXRjcnFQSTVlRG5oX2NabHdBOUVoVm1fNnZsRjQwdFQyblpxcTdoYmFjaU9FdVBOMHdsRm9sUGhDdmFBWVhFelJnc0prQkpGaHZTY2tLQ21kT0lHaEMyTVpadHREbm5lN1ZKSi0yQ2VzRzdGajF3RmFEWDVyMzZnYXVBS1JQbF8tTjNYUUlFNnRVaHZ1MFE?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-17T07:39:58+00:00", "published_display": "17 Jun 2026 07:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk lifts 2026 outlook as Wegovy drives growth; shares jump", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOUHFDeGlNX05nd2l6OE5qYnEwRDhLdkl4bWlnanBvaXQwQUEtLW13bTNURVdBOXlSenJoU1R5YXp4MFBIVkktR0JaWWR3UUlhSFV1TUJCLUN4QnM5OFo4XzNwdHZiMm9CRzlsZDZ3ZU9TNzF5emZRSGhtVGhDMElyZHBTb2hxZGNSRWZfMThSUnpvcFdBdndUQmhLbnZjNDVWM2E2SGJB?oc=5", "source_name": "Investing.com", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk's Weight Loss Doesn't Mean To Load Up (NYSE:NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQQS1MWUpaY19uYWFNZGhHdlZ0VzU1WFowb1BJYXp0VWt3Z19kUzlmQ1k5cnJYTVVYX3otczFHdzdBMWd1NXl4S21YSTJIR1JLcGQ2RWh0V00tOVA2WW5zV2Eza1BQb3NQRnJEMXJOa3g3V0c1Sm10VFhSNEMxVXlkQ3lkczcwNVVtUnZfWE80X2owZmc?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk Just Announced Wegovy Subscriptions. Does That Make NVO Stock a Buy?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNeUFjeXNmZHFzWlZ0dC1jdVlpaDZYYVBVT1YxdGlTMXBibUVGbm9iejdDYW5ZSktsM3ZzREw3YXJLSVlscGNBZFJobnFSem5JaHNDQkZGZTMtTGtta2lfMG1GR3U0eWpMYzNSQmFIa1JwV0pkS3VzemJ0ZlJrLWdaTFRadHNmSUtSQ0dZcWhoMEJwSTlYV09ZcUYzS1lUYWNEWEZyTFBfMDN0aXRiLVNJVWpzYjNzT3l3ZDJfU3Y3eFE?oc=5", "source_name": "Barchart.com", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk stock falls after FDA warning letter", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxNUjZ5WjRrMXp1eXZKemhHWTRYSGlrRk0xRE56blhjREdKNzAtNG1nVkxWOTJIblZhZVhCX3RKM011OHpMZDdUQnJZVWMyNE1tRTFvWmswTldiT3Q3UWdLVGtDdVB5WUFLQ01oWnM3cTlJUUt4WFE5RDJqWnVCV0xWd2JnNlJCZzNuSTNUS1JqUk41eG9iQjRScFZOdHhWa0hfSDBoOVVENmdzeWxIMnhvVg?oc=5", "source_name": "Investing.com", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 6, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here Are Monday\u2019s Top Wall Street Analyst Research Calls: AppLovin, Blue Owl Capital, CrowdStrike, Dutch Bros., Jet Blue, Novo Nordisk, PayPal, Twilio, and More", "summary": "", "url": "https://news.google.com/rss/articles/CBMingJBVV95cUxNaUtPUHB2NkdObG5LcDN6V2ctZEJMbEYzYktVNnhOMkdIekxkVEwwc3dxLV9KU0VnVjhWUFNlbXRrb09GMGk2eklxaWI5TmRWbmVuT0V6dHo5VzJwU2NwSDVZRHAwTDgzaTFTNW5CanJOOHJxU0JaMWw0UEJoX01FU0g4UXV6U1dhODlhU1BodFhBYWJPTUFqVFcxeWFWOW04NEVJNG9qTUgtdjNhUXZsUTEzcHh6b3lxcUJ2UFV0QWRORFRzS1NKRFFLU3RaLTV3RVQ3dmRmaF92bGk0XzNTYVktSUtBRjFUNll0UXlGRnd1clg2V0pwTjZuUW4zUTF1YnZtM2JTbjhVSXpSY3EzSUQwMGVmUDVURXZ6UGNB?oc=5", "source_name": "24/7 Wall St.", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk's $475-billion rise and fall as Wegovy-era gains wiped out", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxPaTdmamc4QU9IekYyT2hOdlVOdlowVjFnZE84b29mN3RuNXFUMURRaUEwTUkzMEwxVllJT3NzdHo3ZjNoYmJmZk41QUpkSTRacmdCd2ZpSVkxdE1icFVXUVVOVUExblRobUpuT2FUSV8td3dCUS00dm5NYU5LYmFTTEdLT0lhQm9naEczT2lySU9GSS1ZUFpEZnNCemFVUk9lejMxR2RBVFNScFBRamlpbEpjQU1iX0RmVjlJVXZJR0k2T2dGZkJWVWItaDY4czE3YkdTT1Fab05tUQ?oc=5", "source_name": "Reuters", "published_at": "2026-02-23T08:00:00+00:00", "published_display": "23 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk Files Patent Lawsuit Against Hims & Hers Over Compounded Semaglutide Products", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxOcUtRUG1LbTVybjF5NTliRXRIeGV3TWVGTGxxT1psSWU5VXQzb0RPQ0RSQWJWWVVQRHVQY0VfOXRJTTdubnVvQWpzWHh4XzRScGFCbEhDODFndUZuVlJ6c25nSnk0VHhkdk1Xd3g5UDdLWmhVb2JLWER4M1l3bjBLUW5NV1hFZFktbWNCTGpzQnU1SUFXV0oyY1dzaVpzdm9jSzc2NnhRbDRrU1ZQRnlqclpLRlUzOTB4b2ZUWVdHOHhJTk9KSVE?oc=5", "source_name": "Law Commentary", "published_at": "2026-02-10T08:00:00+00:00", "published_display": "10 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk shares fall 18% amid lower 2026 sales outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxOQTNhNGZrQ0VEYUxXdllVYzFTRFJRd0VNVlBmS190dE9aRnoyaEtTbnFQTFcyQkVBN1YxYi1sZ0xrZVVWWmg1WW9wTTQzNzdxMFQyVkt4MFZPeEwwbFdnUmF1eGZsZFBleGVtVnVveGZhOFlqUHlOVlZqc0xFQWdBYUVMMS1tNGlPYmRjbU9Iak5KQVh2dW95M0pxM3lQRzFPVWJnRHpzUE9wVUVNNl82eWVPZw?oc=5", "source_name": "Investing.com", "published_at": "2026-02-03T08:00:00+00:00", "published_display": "03 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 6, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk stock soars after FDA approves first oral GLP-1 for weight loss", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxQbkVMUHNPalZHMWRMdUhhT0RSTTBhcDhiel9IcnBmcWNJaWdpclpPMGJjS09yN1VCR1UwVU1IVTlHaEsyQUtxVGFDMXA1ODdUVTFDTmlPWDNjWnQybFB2LU44VXN5aXlpSUxiNGxkNG1IeUE4cVZUOGJMcTRrcTAtcTNXLTJQWWhXaXA5OVUwdlB4RVJwTnk4RG5mN0RINFlSVjVoNXlEdXNlWDZsZkVLVC1nTGVsclJKVEF1MmtMaTZSX0NKNmNtcDJlRFA?oc=5", "source_name": "Investing.com", "published_at": "2025-12-22T08:00:00+00:00", "published_display": "22 Dec 2025 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk's weight-loss challenge in five charts", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxOU1lnS1hva0V3RVpkMl9ZODdJTl9IeVF2UmtQSEVLRFc0VFVCMHpvVDlJZmdrb25BZUlJWlhXUm1Gc212eDk3N1VnQzRta2xSbk9rRFl2TW5vS01nRjFSSThmTE1Idk5qTXc5S2h5RlBzSk1KMWtKMGlTSEhoQ0tsNkItWVNvak5zd1BudzczWlNqWVF0ckIwdkRqTU9JNnE2ZGFqMnNYLTdndVJ2Uy1hU3BtSDc0OVNEclJz?oc=5", "source_name": "Reuters", "published_at": "2025-11-05T08:00:00+00:00", "published_display": "05 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk shares fall as top investor drives board overhaul", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPY2I5NWtFb1VfSDVmdVRyNDhzUUFrcGpOTW56RUE1SWlOaG5nRHRTLU1kMmFxbXdIckNYaU9POXlMLUVzYXB3TjZOcTY3RU1oU3VxemMydXNDLWJvS1BHS2wtMmlpQWlFaHdWckpMOUd3cmFkWkJ1ZnprRXA4ejhObjRWd000RjBiUVRxWHZWeWFUYkpBM3RxcXJNYzlPejctcGVsdGJNWQ?oc=5", "source_name": "Reuters", "published_at": "2025-10-22T07:00:00+00:00", "published_display": "22 Oct 2025 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shares in Novo Nordisk rise after Wegovy gets US nod for liver disease treatment", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxPRUwxUEJDOWFiRUpWQTlOell4VDlsR0hlbDdZR2dfN2FMMVZLRkctNmhORjU4UnVxOUZ1NTU0RXpPTmxwR1lxd0JCcjd3VS1zbHd2RUFBYXh1Z0t5SGs1QnRIM3RNXy1KUDRQWHRCNDI4bk9pb0ZoYml6ZTNndDI4b0NBVzVtX1M0T01rd0xER0lSaHNlQkdKT0MyODZ6WWJBQUh5MUN2dTZXMGJnZXgyMzRSMV92VERiRkZyYWYyMUpNeGI1bEwtUU93R0F2TVZRRVdlak9RVEVGdnlKYUE?oc=5", "source_name": "Reuters", "published_at": "2025-08-18T07:00:00+00:00", "published_display": "18 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novo Nordisk shares fall as obesity pipeline faces investor scrutiny", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxPRURhLU1RbmZtejlyY2lXU2pxeGlXQjlCcHpsOW9uWXNGUTVqMEtCb2VtNDY5cU1yNFliblFXQkZiLWdVbTYxOVVEZkROMGk1UkpTOUJ5Q1pURjRza0t2QjJmcHIwY2Vuc2hIdko1YlB5VjYyTU56d055SFhxdWtLbkFydU9JUFVlTFdzU0g0bEUtRU9hZ1ZZcm9SWC12cU85bFA2LWFndk5WLXVKeU5EclJTSXdTMEM5d19xVkxLRVVERUJSN0hMTnZxV2Rqc2VVcXNz?oc=5", "source_name": "Reuters", "published_at": "2025-06-23T07:00:00+00:00", "published_display": "23 Jun 2025 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 67, "total_relevant": 14, "sentiment_summary": {"positive": 2, "negative": 7, "neutral": 5, "score": 40, "total": 14, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 87, "events": [{"event": "general", "label": "Market update", "weight": 7.95, "count": 10}, {"event": "guidance", "label": "Guidance", "weight": 1.1, "count": 2}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 2, "negative_events": 7}, "market_context": {"has_market_context": true, "latest_close": 770.0, "latest_week": "2026-06-19", "one_week_move": 2.8, "four_week_move": -1.5, "twelve_week_move": 11.3, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.70387, "market_dynamics_buy_signal": false, "relative_strength": -22.3759, "fair_value_gap": -50.6, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 47.636, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+2.8% over one week, -1.5% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 72, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Reuters", "count": 5}, {"label": "Investing.com", "count": 4}, {"label": "Seeking Alpha", "count": 2}, {"label": "Barchart.com", "count": 1}, {"label": "24/7 Wall St.", "count": 1}, {"label": "Law Commentary", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 14}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 10}, {"label": "Guidance", "count": 2}, {"label": "Analyst action", "count": 1}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "40/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "87/100 classification confidence."}, {"label": "Company focus", "value": "14", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "7", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+2.8% over one week, -1.5% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Novo Nordisk: A Fallen Leader Trading At Fair Value, Not A Bargain (NYSE:NVO)"}], "updated_at": "2026-06-22T11:06:20.944968+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}